ArticleACS omega2021

Retraction of "Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy".

Jia-Yang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.